Is Diclegis safe while pregnant?
Taking Diclegis is a safe and effective way to treat nausea and vomiting during pregnancy.
What happens if you crush Diclegis?
Don’t crush, chew, or break the tablet before swallowing. Doing so can cause the medication to last for a shorter period of time in your system. Many over-the-counter allergy, cough, and cold medications can contain antihistamines. Avoid taking these medications with Diclegis (doxylamine / pyridoxine).
Is Diclegis the same as Zofran?
Zofran is used to treat nausea and vomiting due to cancer chemotherapy and also used to prevent and treat nausea and vomiting after surgery. Diclegis is used to treat nausea and vomiting in pregnant women.
Is Zofran better than Diclegis?
1. Pregnant women randomized to receive ondansetron (Zofran) reported greater reduction in both nausea and vomiting than those who received doxylamine-pyridoxine (Diclegis).
Is Zofran stronger than Diclegis?
How many hours does Diclegis last?
The mechanism of action of Diclegis is unknown. Peak plasma concentrations of the doxylamine component occur in 7.5 hours, and the pyridoxine component, 5.5 hours. Elimination half-life is 12.5 hours for the doxylamine component, and in 0.5 hours for the pyridoxine component.
How long does Diclegis stay in system?
Does Diclegis make you sleepy?
It makes you sleepy but it’s not like you can’t get out of bed, they tell you to take 2 before bed another one in the morning and one more at noon, but I’m just taking one before bed time and one in the morning so I don’t feel super sleepy and it works perfectly for me!
Does Zofran cause cleft palate?
Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy. Recent epidemiological studies suggest exposure to ondansetron during the first trimester of pregnancy is associated with a small increased risk of the baby having a cleft lip and/or cleft palate.
How likely is cleft lip with Zofran?
Clinical implications. The recent studies suggest an approximate 25 percent increase in the risk of oral cleft defects with first trimester use of ondansetron, amounting to an additional 3 cases per 10,000 exposed pregnancies.